The Study of the Impact of Disclosing Imaging Study Information to Trial Participants
| Status: | Completed |
|---|---|
| Conditions: | Parkinsons Disease |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | 21 - Any |
| Updated: | 4/5/2019 |
| Start Date: | July 2006 |
| End Date: | August 2008 |
Impact of Disclosure of Dopamine Transporter Imaging Studies in PD Clinical Trials
The overall goal of the study is to evaluate how research participants in Parkinson Disease
studies that include brain imaging with a dopamine transporter ligand choose to receive the
imaging data and what is the impact of the imaging data information on the management of
their symptoms.
studies that include brain imaging with a dopamine transporter ligand choose to receive the
imaging data and what is the impact of the imaging data information on the management of
their symptoms.
Research participants who previously underwent ß-CIT imaging will be contacted by the staff
at IND to enquire whether they would like to receive their ß-CIT scan data. After signing a
Research Participant Information and Consent Form, all research participants will be asked to
complete a questionnaire prior to receipt of their imaging data. Those research participants
requesting imaging data will be sent their data by IND and may review their data with IND (by
phone) and/ or with their study investigator. All research participants will be asked to
respond to a second questionnaire after receiving their imaging data and to a third study
questionnaire approximately six weeks following receipt of their imaging data.
at IND to enquire whether they would like to receive their ß-CIT scan data. After signing a
Research Participant Information and Consent Form, all research participants will be asked to
complete a questionnaire prior to receipt of their imaging data. Those research participants
requesting imaging data will be sent their data by IND and may review their data with IND (by
phone) and/ or with their study investigator. All research participants will be asked to
respond to a second questionnaire after receiving their imaging data and to a third study
questionnaire approximately six weeks following receipt of their imaging data.
Inclusion Criteria:
- Previous participation in imaging study as described within the protocol
Exclusion Criteria:
We found this trial at
1
site
Click here to add this to my saved trials
